Abstract
Background: Females with Ullrich‐Turner syndrome (UTS) have typical clinical features such as short stature, ovarian failure, visible dysmorphic stigmata, and abnormalities in different organs such as kidney or heart.
Hypothesis: The aim of the present study was to analyze the distribution, prevalence, and relative risk of cardiovascular anomalies (CVA) in females with Ullrich‐Turner syndrome (UTS) seen at one single center compared with that of the regional Bavarian population.
Methods: The associations between CVA and karyotype were determined. In all, 117 girls and women with UTS, aged between 3 and 43 years (median 17.4 years) were studied retrospectively. The detailed cardiologic status including echo‐cardiography was available in all patients. The prevalences of each cardiovascular anomaly were determined. On the basis of published epidemiologic data of CVA in Bavarian children, we assessed the relative risks of each CVA.
Results: Thirty‐five (29.9%) girls with UTS had at least one CVA. In all of these CVAs, coarctation of the aorta and bicuspid aortic valve occurred most often (18.5% each). The aortic malformations represented over two‐thirds of all CVA (72.8%), whereas anomalies of the septum (8.6%), mitral valve (6.2%), pulmonary veins (4.9%), and other locations together accounted for the otherthird. Bicuspid aortic valve and partial anomalous pulmonary venous drainage were associated with the highest relative risk (RR) (3,603 and 1,293, respectively) compared with the Bavarian population. The overall RR of CVA was 48.7. Of the 117 girls and women examined, 64 (54.7%) had complete monosomy 45 X.
Conclusions: Our data demonstrate that about every third female with UTS is affected with at least one CVA, mainly left sided and associated with aortic structures. Our results underline the necessity of thorough cardiologic evaluation.
Keywords: Ullrich‐Turner syndrome, congenital heart disease, cardiovascular anomalies
Full Text
The Full Text of this article is available as a PDF (42.3 KB).
References
- 1. Gotzsche CO, Krag‐Olsen B, Nielsen J, Sorensen KE, Kristensen BO: Prevalence of cardiovascular malformations and association with karyotypes in Turner's syndrome. Arch Dis Child 1994; 71: 433–436 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Lin AE: Management of cardiac problems In Optimizing Health Care for Turner Patients in the 21st Century (1st Ed.) (Eds. Saenger P, Pasquino AM.), p. 115 Amsterdam, The Netherlands: Elsevier Science B.V., 2000. [Google Scholar]
- 3. Mazzanti L, Cacciari E: Congenital heart disease in patients with Turner's syndrome. Italian Study Group for Turner Syndrome (ISGTS). J Pediatr 1998; 133: 688–692 [DOI] [PubMed] [Google Scholar]
- 4. de Muinck Keizer‐Schrama SM, Sas TC: Growth hormone treatment regimens in girls with Turner syndrome. Dutch Advisory Group on Growth Hormone. Acta Paediatr 1999; 88 (suppl): 126–129 [DOI] [PubMed] [Google Scholar]
- 5. Rochiccioli P, Battin J, Bertrand AM, Bost M, Cabrol S, le Bouc Y, Chaussain JL, Chatelain P, Colle M, Czernichow P: Final height in Turner syndrome patients treated with growth hormone. Horm Res 1995; 44: 172–176 [DOI] [PubMed] [Google Scholar]
- 6. Sas TC, de Muinck Keizer‐Schrama SM, Stijnen T, Jansen M, Otten BJ, Hoorweg‐Nijman JJ, Vulsma T, Massa GG, Rouwe CW, Reeser HM, Gerver WJ, Gosen JJ, Rongen‐Westerlaken C, Drop SL: Normalization of height in girls with Turner syndrome after long‐term growth hormone treatment: Results of a randomized dose‐response trial. J Clin Endocrinol Metab 1999; 84: 4607–4612 [DOI] [PubMed] [Google Scholar]
- 7. Ranke MB, Partsch CJ, Lindberg A, Dorr HG, Bettendorf M, Hauffa BP, Schwarz HP, Mehls O, Sander S, Stahnke N, Steinkamp H, Said E, Sippell W: Adult height after GH therapy in 188 Ullrich‐Turner syndrome patients: Results of the German IGLU follow‐up study 2001. Eur J Endocrinol 2002; 147: 625–633 [DOI] [PubMed] [Google Scholar]
- 8. Saenger P, Pasquino AM: Optimizing Health Care for Turner Patients in the 21st Century. (1st Ed.). Amsterdam, The Netherlands: Elsevier Science B.V., 2000. [Google Scholar]
- 9. Schoetzau A, van Santen F, Sauer U, Irl C: Cardiovascular abnormalities in Bavaria 1984‐1991. Z Kardiol 1997; 86: 496–504 [DOI] [PubMed] [Google Scholar]
- 10. Price WH, Clayton JF, Collyer S, De Mey R, Wilson J: Mortality ratios, life expectancy, and causes of death in patients with Turner's syndrome. J Epidemiol Community Health 1986; 40: 97–102 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Mazzanti L, Prandstraller D, Tassinari D, Rubino I, Santucci S, Picchio FM, Forabosco A, Cacciari E: Heart disease in Turner's syndrome. Helv Paediatr Acta 1988; 43: 25–31 [PubMed] [Google Scholar]
- 12. Prandstraller D, Mazzanti L, Picchio FM, Magnani C, Bergamaschi R, Perri A, Tsingos E, Cacciari E: Turner's syndrome: Cardiologic profile according to the different chromosomal patterns and long‐term clinical follow‐up of 136 nonpreselected patients. Pediatr Cardiol 1999; 20: 108–112 [DOI] [PubMed] [Google Scholar]
- 13. Keith JD: Prevalence, incidence and epidemiology In Heart Disease in Infancy and Childhood (Ed. Rowe K, Vlad P.), p. 3 New York: MacMillan Publishing Co Inc., 1978. [Google Scholar]
- 14. Cripe L, Andelfinger G, Martin LJ, Shooner K, Benson DW: Bicuspid aortic valve is heritable. J Am Coll Cardiol 2004; 44: 138–143 [DOI] [PubMed] [Google Scholar]
- 15. Zinn AR, Ouyang B, Ross JL, Varma S, Bourgeois M, Tonk V: Del (X)(P21.2) in a mother and two daughters with variable ovarian function. Clin Genet 1997; 52: 235–239 [DOI] [PubMed] [Google Scholar]
- 16. James RS, Coppin B, Dalton P, Dennis NR, Mitchell C, Sharp AJ, Skuse DH, Thomas NS, Jacobs PA: A study of females with deletions of the short arm of the X chromosome. Hum Genet 1998; 102: 507–516 [DOI] [PubMed] [Google Scholar]
- 17. Zinn AR, Tonk VS, Chen Z, Flejter WL, Gardner HA, Guerra R, Kushner H, Schwartz S, Sybert VP, Van Dyke DL, Ross JL: Evidence for a Turner syndrome locus or loci at Xp11.2‐P22.1. Am J Hum Genet 1998; 63: 1757–1766 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Belin V, Cusin V, Viot G, Girlich D, Toutain A, Moncla A, Vekemans M, Le Merrer M, Munnich A, Cormier‐Daire V: SHOX mutations in dyschondrosteosis (Leri‐Weill Syndrome). Nat Genet 1998; 19: 67–69 [DOI] [PubMed] [Google Scholar]
- 19. Clement‐Jones M, Schiller S, Rao E, Blaschke RJ, Zuniga A, Zeller R, Robson SC, Binder G, Glass I, Strachan T, Lindsay S, Rappold GA: The short stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syndrome. Hum Mol Genet 2000; 9: 695–702 [DOI] [PubMed] [Google Scholar]
- 20. Shears DJ, Vassal HJ, Goodman FR, Palmer RW, Reardon W, Superti‐Furga A, Scambler PJ, Winter RM: Mutation and deletion of the pseudoautosomal gene SHOX cause Leri‐Weill dyschondrosteosis. Nat Genet 1998; 19: 70–73 [DOI] [PubMed] [Google Scholar]
- 21. Jones KL: Smith's Recognizable Patterns of Human Malformations: Genetic, Embryonic and Clinical Aspects. (4th Ed.). Philadelphia: W. B. Saunders, 1988. [Google Scholar]
- 22. Lacro RV, Jones KL, Benirschke K: Coarctation of the aorta in Turner syndrome: A pathologic study of fetuses with nuchal cystic hygromas, hydrops fetalis, and female genitalia. Pediatrics 1988; 81: 445–451 [PubMed] [Google Scholar]
- 23. Ogata T, Matsuo N: Turner syndrome and female sex chromosome aberrations : Deduction of the principal factors involved in the development of clinical features. Hum Genet 1995; 95: 607–629 [DOI] [PubMed] [Google Scholar]
- 24. Witt DR, Hoyme HE, Zonana J, Manchester DK, Fryns JP, Stevenson JG, Curry CJ, Hall JG: Lymphedema in Noonan syndrome: Clues to pathogenesis and prenatal diagnosis and review of the literature. Am J Med Genet 1987; 27: 841–856 [DOI] [PubMed] [Google Scholar]
- 25. Ogata T, Sato S, Hasegawa Y, Kosaki K: Lymphstasis in a boy with Noonan syndrome: Implication for the development of skeletal features. Endocr J 2003; 50: 319–324 [DOI] [PubMed] [Google Scholar]
- 26. Boucher CA, Sargent CA, Ogata T, Affara NA: Breakpoint analysis of Turner patients with partial Xp deletions: Implications for the lymphoedema gene location. J Med Genet 2001; 38: 591–598 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Ogata T, Muroya K, Matsuo N, Shinohara O, Yorifuji T, Nishi Y, Hasegawa Y, Horikawa R, Tachibana K: Turner syndrome and Xp deletions: Clinical and molecular studies in 47 patients. J Clin Endocrinol Metab 2001; 86: 5498–5508 [DOI] [PubMed] [Google Scholar]
- 28. Marino B, Digilio MC, Toscano A, Giannotti A, Dallapiccola B: Congenital heart diseases in children with Noonan syndrome: An expanded cardiac spectrum with high prevalence of atrioventricular canal. J Pediatr 1999; 135: 703–706 [DOI] [PubMed] [Google Scholar]
- 29. Buheitel G, Singer H, Hofbeck M: Aortic aneurysms in Ullrich‐Turner syndrome. Klin Padiatr 1996; 208: 42–45 [DOI] [PubMed] [Google Scholar]
- 30. Bordeleau L, Cwinn A, Turek M, Barron‐Klauninger K, Victor G: Aortic dissection and Turner's syndrome: Case report and review of the literature. J Emerg Med 1998; 16: 593–596 [DOI] [PubMed] [Google Scholar]
- 31. Landin‐Wilhelmsen K, Bryman I, Wilhelmsen L: Cardiac malformations and hypertension, but not metabolic risk factors, are common in Turner syndrome. J Clin Endocrinol Metab 2001; 86: 4166–4170 [DOI] [PubMed] [Google Scholar]
- 32. Lin AE, Lippe B, Rosenfeld RG: Further delineation of aortic dilation, dissection, and rupture in patients with Turner syndrome. Pediatrics 1998; 102: e12 (p. 1–9) [DOI] [PubMed] [Google Scholar]
- 33. Price WH, Wilson J: Dissection of the aorta in Turner's syndrome. J Med Genet 1983; 20: 61–63 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Silverman BL, Friedlander JR: Is growth hormone good for the heart? J Pediatr 1997; 131: S70–S74 [DOI] [PubMed] [Google Scholar]
- 35. Sas TC, Cromme‐Dijkhuis AH, de Muinck Keizer‐Schrama SM, Stijnen T, van Teunenbroek A, Drop SL: The effects of long‐term growth hormone treatment on cardiac left ventricular dimensions and blood pressure in girls with Turner's syndrome. Dutch Working Group on Growth Hormone. J Pediatr 1999; 135: 470–476 [DOI] [PubMed] [Google Scholar]